Brought to you by 
SpringWorks nets $173.3mm via IPO
18 Sep 2019
Executive Summary
SpringWorks Therapeutics Inc. (developing treatments for cancer and rare diseases) netted $173.3mm through its initial public offering of 10.35mm common shares (including the overallotment) at $18. The company originally intended to sell 7.35mm shares at a range of $16-18.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SpringWorks nets $173.3mm via IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice